MFDS — authorised 21 September 2000
- Marketing authorisation holder: SALIX PHARMS
- Status: likely_approved
🇰🇷 Osmoprep in South Korea
MFDS authorised Osmoprep on 21 September 2000
Marketing authorisation
Osmoprep in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Osmoprep approved in South Korea?
Yes. MFDS authorised it on 21 September 2000.
Who is the marketing authorisation holder for Osmoprep in South Korea?
SALIX PHARMS holds the South Korean marketing authorisation.